Effect of Octreotide on Human Sphincter of Oddi Motility Following Liver Transplantation

被引:0
作者
Frederick H. Weber
Richard John Sears
B. Kendall
Timothy L. Pruett
Hubert A. Shaffer
Paul Yeaton
机构
来源
Digestive Diseases and Sciences | 1997年 / 42卷
关键词
BILIARY TRACT; GASTROINTESTINAL MOTILITY; OCTREOTIDE; SPHINCTER OF ODDI;
D O I
暂无
中图分类号
学科分类号
摘要
The effect of octreotide on sphincter of Oddimotility was investigated in six liver transplantpatients, employing percutaneous (through the T-tubetract) manometry. Continuous and simultaneous sphincter of Oddi and duodenal motor activities wererecorded before and for 60 min after the administrationof octreotide (100 μg subcutaneously) and after theinjection of cholecystokinin (0.02 μg/kgintravenously). With octreotide, contraction frequency andbasal pressure significantly increased (P < 0.05).This effect lasted more than 60 min, long afteroctreotide-induced duodenal migrating motor complexphase III activity had ceased. Sphincter of Oddicontraction amplitude and duration were unaffected byoctreotide. Subsequent cholecystokinin administrationtransiently reduced sphincter of Oddi basal pressure and contraction frequency. We conclude thatoctreotide significantly increases sphincter of Oddibasal pressure and contraction frequency. This effect isdistinct from octreotide induction of migrating motor complex phase III activity, persists for aprolonged period, and is inhibited bycholecystokinin.
引用
收藏
页码:1168 / 1175
页数:7
相关论文
共 157 条
[1]  
Lucey MR(1989)Biochemistry and physiology of gastrointestinal somatostatin Dig Dis Sci 34 5S-13S
[2]  
Yamada T(1989)Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Ann Intern Med 110 35-50
[3]  
Gordon P(1990)Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide Am J Gastroenterol 85 1061-1072
[4]  
Comi RJ(1978)Effect of somatostatin on the pancreatitis-like biochemical changes due to endoscopic pancreatography: Preliminary report Metabolism 27 1333-1336
[5]  
Maton PN(1986)Effect of somatostatin on hyperamylasemia following endoscopic pancreatography Acta Chir Scand Suppl 530 43-45
[6]  
Go VLW(1988)Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing retrograde cholangiopancreatography and endoscopic sphincterotomy Horm Res 29 106-108
[7]  
Grossman I(1991)The effect of long acting somatostatin analogue on enzyme changes after endoscopic pancreatography Gastrointest Endosc 37 48-50
[8]  
Simon D(1992)A multicenter randomized, controlled trial to evaluate the effect of octreotide on post-ERCP pancreatitis Am J Gastroenterol 85 1561-1566
[9]  
Tamas G(1992)Does the somatostatin analogue octreotide protect against ERCP-induced pancreatitis? Gut 33 1129-1133
[10]  
Tulassay Z(1994)The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy Endoscopy 26 715-718